International Flavors & Fragrances Inc. (IFF) is a Materials stock trading at $84.31 (as of 2026-08-21), with a market capitalization of $21.51B and a trailing P/E of 80.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
International Flavors & Fragrances (IFF), through its Nourish, Scent, Health & Biosciences, and Pharma Solutions segments, develops, manufactures, and sells ingredients used in food, fragrance, and health and pharmaceutical applications. It supplies cosmetic actives and natural health ingredients to customers in regions including Europe, Africa, the Middle East, Greater Asia, North America, and Latin America.
International Flavors & Fragrances (IFF) manufactures and sells cosmetic active and natural health ingredients, as well as natural and plant-based specialty food ingredients, to be used in other manufacturers' consumer products, and it earns money by selling these specialty ingredient formulations across its Nourish, Scent, Health & Biosciences, and Pharma Solutions segments.
IFF’s profit model is built on selling manufactured specialty ingredients into other companies' final consumer products across multiple end-markets (food, scent/personal care, health/biosciences, and pharma), so segment demand mix drives overall performance.
| Nourish | $1.5B |
| Scent | $0.6B |
| Health & Biosciences | $0.6B |
| Pharma Solutions | $0.3B |
Business quality (Weak): IFF is a specialty ingredients manufacturer with clear, reportable segment lines (Nourish, Scent, Health & Biosciences, Pharma Solutions), which helps investors see where sales come from. The main risk is segment-level volatility, since different segments can face different customer and end-market conditions.
Valuation: At 23× earnings, IFF trades 39% below the Chemicals average (38×). Note: one-time items can distort reported P/E.
| Price | $84.31 |
| Market Cap | $21.51B |
| P/E Ratio | 80.9 |
| EV / EBITDA | 15.7 |
| Price / Book | 1.54 |
| Price / Sales | 2.16 |
| FCF Yield | 2.5% |
| DCF Value (model) | $43.22 |
| DCF Upside vs Price | -48.7% |
| Revenue (TTM) | $10.89B |
| Net Margin | -3.3% |
| Revenue Growth (YoY) | -29.3% |
| EPS Growth (YoY) | -91.6% |
| FCF Growth (YoY) | 95.9% |
| Altman Z-Score | 1.41 (distress) |
| Piotroski F-Score | 6/9 (moderate) |
| Stock P/E | 80.9 |
| Sector P/E (Materials) | 25.9 |
| Industry P/E (Chemicals) | 31.1 |
| vs Sector | 212.1% |
| vs Industry | 159.7% |
| Top Institutional Holder | Dodge & Cox ($2.65B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 10 |
| Sector | Materials |
| Industry | Chemicals |
| CEO | Jon Erik Fyrwald |
| Employees | 22,400 |
| Country | US |
| IPO Date | 1974-12-17 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.